Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure
International Journal of Rheumatic Diseases · 2023-05 · 26 (5) · 862-869
DOI: 10.1111/1756-185x.14660 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 09.03.2023. Verfasst von Xiaoyue Deng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical …. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Connective Tissue Diseases, Pulmonary Arterial Hypertension, Heart Failure. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Beijing Municipal Science & Technology Commission (No. Z201100005520026), CAMS Innovation Fund for Medical Sciences (CIFMS) (grant number: 2021-I2M-1-005), Chinese National Key Technology R&D Program, Ministry of Science and Technology (grant number: 2021YFC2501305).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Objective
To identify predictive factors associated with mortality in connective tissue disease‐associated pulmonary arterial hypertension (CTD‐PAH) patients who were complicated with right heart failure (RHF).
Methods
In this single‐center retrospective study, baseline demographics, clinical features, laboratory results, and hemodynamic assessments were collected. Kaplan–Meier analysis was applied to analyze all‐cause mortality. Univariate and forward stepwise multivariate Cox proportional regression analyses were performed to identify independent predictors of mortality.
Results
A total of 51 right heart catheterization‐confirmed CTD‐PAH patients complicated with RHF were consecutively enrolled in this study from 2012 to 2022. Forty‐eight (94%) enrolled patients were female and the mean age was 36.0 ± 11.8 years. Thirty‐two (61.5%) were systemic lupus erythematosus‐PAH and 33%/67% showed World Health Organization functional class III/IV, respectively. Twenty‐five (49%) of those patients died and Kaplan–Meier analysis showed the overall 1‐, 3‐, and 5‐week survival rates from the time of hospitalization as 86.28%, 60.78%, and 56.86%, respectively. RHF in CTD‐PAH patients mainly resulted from progression of PAH ( n = 19) and infection ( n = 5), which also contributed to the leading causes of death. Statistical analysis between survivors and non‐survivors showed that death from RHF was associated with higher levels of urea (9.66 vs 6.34 mmol/L, P = 0.002), lactate (cLac: 2.65 vs 1.9 mmol/L, P = 0.006), total bilirubin (23.1 vs 16.9 μmol/L, P = 0.018) and direct bilirubin (10.5 vs 6.5 μmol/L, P = 0.004), but with lower levels of hematocrit (33.7 vs 39, P = 0.004), cNa+ (131 vs 136 mmol/L, P = 0.003). Univariate and forward stepwise multivariate Cox proportional regression analyses indicated that the level of cLac (hazards ratio:1.297; 95% CI: 1.076–1.564; P = 0.006) was an independent risk factor for mortality.
Conclusion
The short‐term prognosis of CTD‐PAH complicated with RHF was very poor, and hyperlactic acidemia (cLac > 2.85 mmoL/L) was an independent predicting factor for mortality of CTD‐PAH patients complicated with RHF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immuno…
- Medical Science Research Center (MRC), Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
- Medical Intensive Care Unit, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
ORCID-Profile: Xiaoyue Deng, Nan Jiang, Jiaxin Zhou
Förderung
- Beijing Municipal Science & Technology Commission (No. Z201100005520026)
- CAMS Innovation Fund for Medical Sciences (CIFMS) (grant number: 2021-I2M-1-005)
- Chinese National Key Technology R&D Program, Ministry of Science and Technology (grant number: 2021YFC2501305)
- National High Level Hospital Clinical Research Funding (2022-PUMCH-A-008)
- National Natural Science Foundation of China
Zitieren
APA
Deng, X., Jiang, N., Huang, C., Zhou, S., Peng, L., Zhang, L., Liu, J., Wang, L., Zhou, J., Wang, Q., Weng, L., Peng, J., Zhao, J., Li, M., & Zeng, X. (2023). Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure. International Journal of Rheumatic Diseases, 26(5), 862-869. https://doi.org/10.1111/1756-185x.14660
Vancouver
Deng X, Jiang N, Huang C, Zhou S, Peng L, Zhang L, et al. Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure. International Journal of Rheumatic Diseases. 2023;26(5):862-869. doi:10.1111/1756-185x.14660
BibTeX
@article{Deng2023,
author = {Deng, Xiaoyue and Jiang, Nan and Huang, Can and Zhou, Shuang and Peng, Linyi and Zhang, Li and Liu, Jinjing and Wang, Li and Zhou, Jiaxin and Wang, Qian and Weng, Li and Peng, Jinmin and Zhao, Jiuliang and Li, Mengtao and Zeng, Xiaofeng},
title = {Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
volume = {26},
number = {5},
pages = {862--869},
doi = {10.1111/1756-185x.14660}
}
EUVIMED